浙江临床医学
浙江臨床醫學
절강림상의학
ZHEJIANG CLINICAL MEDICAL JOURNAL
2014年
11期
1693-1695
,共3页
沈笑春%陈延斌%穆传勇%雷伟%黄建安
瀋笑春%陳延斌%穆傳勇%雷偉%黃建安
침소춘%진연빈%목전용%뢰위%황건안
肺癌%CD40/CD40L%血小板酶联免疫吸附试验%流式细胞术
肺癌%CD40/CD40L%血小闆酶聯免疫吸附試驗%流式細胞術
폐암%CD40/CD40L%혈소판매련면역흡부시험%류식세포술
lung cancer%CD40/CD40 ligand%platelet%ELISA%flow cytometry
目的:通过测定肺癌患者血小板源性CD40、CD40配体(CD40L)、CD62P的表达水平,探讨血小板源性CD40/CD40L在肺癌外周血中的表达及其临床意义。方法体外分离肺癌患者的血小板,用二磷酸腺苷(ADP)体外诱导前后采用流式细胞仪对其表面表达的CD40、CD40L、CD62P进行测定,并与健康人作比较。结果(1)ADP诱导前,肺癌组血小板源性CD40、CD40L、CD62P表达水平明显高于对照组(P均<0.01)。ADP诱导后,肺癌组血小板源性CD40、CD62P表达水平明显高于对照组(P均<0.01)(2)ADP诱导前后,不同病理类型肺癌患者血小板源性CD40、CD40L、CD62P表达水平的差异均无统计学意义(P均>0.05)。(3)ADP诱导前后,有远处转移患者血小板源性CD40L、CD62P表达水平明显高于无远处转移患者(P<0.05)。结论(1)肺癌患者血小板源性CD62P、CD40L表达水平增加,且表达水平与肺癌的进展程度相关,血小板源性CD40/CD40L系统在肺癌的发病中具有重要作用。(2)检测血小板源性CD40L、CD62P表达水平对研究肺癌的临床分期、预后判断有一定的参考价值。
目的:通過測定肺癌患者血小闆源性CD40、CD40配體(CD40L)、CD62P的錶達水平,探討血小闆源性CD40/CD40L在肺癌外週血中的錶達及其臨床意義。方法體外分離肺癌患者的血小闆,用二燐痠腺苷(ADP)體外誘導前後採用流式細胞儀對其錶麵錶達的CD40、CD40L、CD62P進行測定,併與健康人作比較。結果(1)ADP誘導前,肺癌組血小闆源性CD40、CD40L、CD62P錶達水平明顯高于對照組(P均<0.01)。ADP誘導後,肺癌組血小闆源性CD40、CD62P錶達水平明顯高于對照組(P均<0.01)(2)ADP誘導前後,不同病理類型肺癌患者血小闆源性CD40、CD40L、CD62P錶達水平的差異均無統計學意義(P均>0.05)。(3)ADP誘導前後,有遠處轉移患者血小闆源性CD40L、CD62P錶達水平明顯高于無遠處轉移患者(P<0.05)。結論(1)肺癌患者血小闆源性CD62P、CD40L錶達水平增加,且錶達水平與肺癌的進展程度相關,血小闆源性CD40/CD40L繫統在肺癌的髮病中具有重要作用。(2)檢測血小闆源性CD40L、CD62P錶達水平對研究肺癌的臨床分期、預後判斷有一定的參攷價值。
목적:통과측정폐암환자혈소판원성CD40、CD40배체(CD40L)、CD62P적표체수평,탐토혈소판원성CD40/CD40L재폐암외주혈중적표체급기림상의의。방법체외분리폐암환자적혈소판,용이린산선감(ADP)체외유도전후채용류식세포의대기표면표체적CD40、CD40L、CD62P진행측정,병여건강인작비교。결과(1)ADP유도전,폐암조혈소판원성CD40、CD40L、CD62P표체수평명현고우대조조(P균<0.01)。ADP유도후,폐암조혈소판원성CD40、CD62P표체수평명현고우대조조(P균<0.01)(2)ADP유도전후,불동병리류형폐암환자혈소판원성CD40、CD40L、CD62P표체수평적차이균무통계학의의(P균>0.05)。(3)ADP유도전후,유원처전이환자혈소판원성CD40L、CD62P표체수평명현고우무원처전이환자(P<0.05)。결론(1)폐암환자혈소판원성CD62P、CD40L표체수평증가,차표체수평여폐암적진전정도상관,혈소판원성CD40/CD40L계통재폐암적발병중구유중요작용。(2)검측혈소판원성CD40L、CD62P표체수평대연구폐암적림상분기、예후판단유일정적삼고개치。
Objective To investigate the expressions of platelet-derived CD40、CD40 ligand(CD40L) in patients with lung cancer,and to evaluate the clinical signif icance of platelet-derived CD40/CD40L in lung cancer.Methods:Platelets were isolated from patients with lung cancer and normal subjects.The expression rates of platelet-derived CD40、CD40L、CD62P were measured by flow cytometry before and after adenosine diphosphate(ADP) inducing in vitro. Results (1) The expression of platelet-derived CD40、CD40L、CD62P were significantly increased in patients with lung cancer as compared with normal volunteers before induced by ADP(P<0.01).After induced by ADP,the expression of CD40、CD62P in patients were significantly higher than those of normal volunteers(P<0.01).(2) Before and after induced by ADP,the expression of platelet-derived CD40、CD40L、CD62P showed no statistically significant difference among all pathological types of patients with lung cancer(P>0.05).(3) Before and after induced by ADP,The expression of platelet-derived CD40L and CD62P were higher in the patients with metastasis than those of without metastasis(P<0.05).Conclusions (1)These results suggested that there were high levels expression of platelet-derived CD40L、CD62P in patients with lung cancer.Therefore the levels of them were correlated with the stages of lung cancer.The system of platelet-derived CD40/CD40L might have a potent effect in pathogenesis of lung cancer.(2) Measurement of platelet-derived CD40L、CD62P may therefore provide a tool for monitoring the clinical course of lung cancer.